Gaspar HJ, Marco Antonio Peña DMA, Martínez RMA

Idioma: Español
Referencias bibliográficas: 10
Paginas: 86-87
Archivo PDF: 41.94 Kb.

FRAGMENTO

Insuficiencia cardíaca aguda
Diagnóstico en sala de hemodinámica
INC 1 e INC 2
Debido a la precisión diagnóstica de los métodos no invasivos actuales, como los invasivos aplicados en la cama del enfermo (catéter de flotación), no existe indicación clase 1 ó 2 para el cateterismo cardíaco.

REFERENCIAS (EN ESTE ARTÍCULO)

1. RYAN TJ, FAXON DP, GUNNAR RM, ET AL: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486–502.

2. KEELEY EC, BOURA JA, GRINES CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361: 13–20.

3. TIEFENBRUNN AJ, CHANDRA NC, FRENCH WJ, ET AL: Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998; 31: 1240–1245.

4. BRODIE BR, STUCKEY TD, HANSEN C, ET AL: Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85: 13–18.

5. GRINES CL, COX DA, STONE GW, ET AL, for the Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999; 341: 1949–1956.

6. SCHELLER B, HENNEN B, SEVERIN-KNEIB S, ET AL: Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction. Am J Med 2001; 110: 1–6.

7. JULIARD JM, FELDMAN LJ, GOLMARD JL, ET AL: Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am J Cardiol 2003; 91: 1401–1405.

8. ANDERSON HV, SHAW RE, BRINDIS RG, HEWITT K, KRONE RJ, BLOCK PB, MCKAY CR, WEINTRAUB WS, on behalf of the ACC-NCDR. A contemporary overview of percutaneous coronary interventions: the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002; 39: 1096–1103.

9. HARRELL L, SCHUNKERT EH, PALACIOS IF: Risk predictors in patients scheduled for percutaneous coronary revascularization. Cathet Cardiovas Intervent 1999; 48: 253–260.

10. LAARMAN GJ, SUTTORP MJ, DIRKSEN MT, ET AL: Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006; 14, 355(11): 1105-13.